Heterogeneity, inherent and acquired drug resistance in patient-derived organoid models of primary liver cancer
-
Published:2022-08-29
Issue:5
Volume:45
Page:1019-1036
-
ISSN:2211-3428
-
Container-title:Cellular Oncology
-
language:en
-
Short-container-title:Cell Oncol.
Author:
Xian Linfeng, Zhao Pei, Chen Xi, Wei Zhimin, Ji Hongxiang, Zhao Jun, Liu Wenbin, Li Zishuai, Liu Donghong, Han Xue, Qian Youwen, Dong Hui, Zhou Xiong, Fan Junyan, Zhu Xiaoqiong, Yin Jianhua, Tan Xiaojie, Jiang Dongming, Yu Hongping, Cao GuangwenORCID
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Molecular Medicine,General Medicine
Reference59 articles.
1. H. Sung, J. Ferlay, R.L. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal, F. Bray, Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209–249 (2021) 2. D. Jiang, L. Zhang, W. Liu, Y. Ding, J. Yin, R. Ren, Q. Li, Y. Chen, J. Shen, X. Tan, H. Zhang, G. Cao, Trends in cancer mortality in China from 2004 to 2018: A nationwide longitudinal study. Cancer Commun. (Lond.) 41, 1024–1036 (2021) 3. F. Yang, L. Ma, Y. Yang, W. Liu, J. Zhao, X. Chen, M. Wang, H. Zhang, S. Cheng, F. Shen, H. Wang, W. Zhou, G. Cao, Contribution of hepatitis B virus infection to the aggressiveness of primary liver cancer: A clinical epidemiological study in eastern China. Front. Oncol. 9, 370 (2019) 4. G. Marasco, F. Ravaioli, A. Vestito, B. Rossini, E. Dajti, L. Colecchia, K. Gjini, M. Renzulli, R. Golfieri, D. Festi, A. Colecchia, Predictive factors for hepatocellular carcinoma recurrence after curative treatments. Hepatoma Res. 6, 33 (2020) 5. A. Rammohan, M. Rela, Risk factors and management of post-liver transplant recurrence of hepatocellular carcinoma. Hepatoma Res. 7, 49 (2021)
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|